机构:[1]Hebei Clinical Research Center for Chronic Kidney Disease, Hebei Key Laboratory of Vascular Calcification in Kidney Disease, Departments of Nephrology, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China临床科室肾内科河北医科大学第四医院
The project of Hebei Science and
Technology Planning, Grant/Award
Number: 16397733D; the project of the
Hebei Major Medical Science, Grant/
Award Number: GL2011-51;
Hebei
province medical technology tracking
project, Grant/Award Number: G2018050
第一作者机构:[1]Hebei Clinical Research Center for Chronic Kidney Disease, Hebei Key Laboratory of Vascular Calcification in Kidney Disease, Departments of Nephrology, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China
通讯作者:
通讯机构:[1]Hebei Clinical Research Center for Chronic Kidney Disease, Hebei Key Laboratory of Vascular Calcification in Kidney Disease, Departments of Nephrology, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China[*1]Department of Nephrology, the Fourth Hospital of Hebei Medical University, 12 Jiankang Road, Shijiazhuang, 050011, China.
推荐引用方式(GB/T 7714):
Bai Yaling,Xu Jinsheng,Yang Shuo,et al.The intermediate-conductance calcium-activated potassium channel KCa3.1 contributes to alkalinization-induced vascular calcification in vitro.[J].JOURNAL OF CLINICAL LABORATORY ANALYSIS.2021,35(8):doi:10.1002/jcla.23854.
APA:
Bai Yaling,Xu Jinsheng,Yang Shuo,Zhang Huiran,He Lei...&Zhang Shenglei.(2021).The intermediate-conductance calcium-activated potassium channel KCa3.1 contributes to alkalinization-induced vascular calcification in vitro..JOURNAL OF CLINICAL LABORATORY ANALYSIS,35,(8)
MLA:
Bai Yaling,et al."The intermediate-conductance calcium-activated potassium channel KCa3.1 contributes to alkalinization-induced vascular calcification in vitro.".JOURNAL OF CLINICAL LABORATORY ANALYSIS 35..8(2021)